Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Acq. announced
CC transcript
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/19/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2022 SC 13G ARMISTICE CAPITAL, LLC reports a 6.6% stake in Madrigal Pharmaceuticals, Inc.
02/12/2021 SC 13G Avoro Capital Advisors LLC reports a 7.9% stake in Madrigal Pharmaceuticals, Inc.
02/02/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/11/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/28/2020 SC 13G WELLINGTON MANAGEMENT GROUP LLP reports a 6.2% stake in Madrigal Pharmaceuti
02/13/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/10/2018 SC 13G Capital Research Global Investors reports a 10.8% stake in Madrigal Pharmaceuticals, Inc.
02/13/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/10/2012 SC 13G FMR LLC reports a 10.5% stake in SYNTA PHARMACEUTICALS CORP
02/09/2012 SC 13G SYNTA PHARMACEUTICALS CORP reports a 8.8% stake in SYNTA PHARMACEUTICALS CORP
02/14/2008 SC 13G Bahcall Safi R reports a 6.8% stake in SYNTA PHARMACEUTICALS CORP.
02/14/2008 SC 13G Chen Lan Bo reports a 10.1% stake in SYNTA PHARMACEUTICALS CORP.
02/16/2007 SC 13G Luxor Capital Group, LP reports a 6.3% stake in Synta Pharmaceuticals Corp.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy